Title |
Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada - Volume 24, Number 10—October 2018 - Emerging Infectious Diseases journal - CDC
|
---|---|
Published in |
Emerging Infectious Diseases, October 2018
|
DOI | 10.3201/eid2410.171711 |
Pubmed ID | |
Authors |
Alefiya Neemuchwala, Sarah Teatero, Lindsay Liang, Irene Martin, Walter Demzcuk, Allison McGeer, Nahuel Fittipaldi |
Abstract |
Two genetically dissimilar sequence type 1 clades dominate the serotype VI group B Streptococcus population of strains causing invasive disease in Canada. Isolates of this rare serotype, recovered mainly from adult patients, were all susceptible to penicillin and vancomycin. However, we observed resistance to erythromycin and clindamycin. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 2 | 11% |
Researcher | 2 | 11% |
Student > Master | 2 | 11% |
Student > Bachelor | 1 | 6% |
Student > Ph. D. Student | 1 | 6% |
Other | 0 | 0% |
Unknown | 10 | 56% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 22% |
Immunology and Microbiology | 2 | 11% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Veterinary Science and Veterinary Medicine | 1 | 6% |
Engineering | 1 | 6% |
Other | 0 | 0% |
Unknown | 9 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2018.
All research outputs
#13,388,707
of 23,102,082 outputs
Outputs from Emerging Infectious Diseases
#6,819
of 9,157 outputs
Outputs of similar age
#168,218
of 343,708 outputs
Outputs of similar age from Emerging Infectious Diseases
#84
of 125 outputs
Altmetric has tracked 23,102,082 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,157 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.9. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,708 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.